Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ARTIVION, INC.AORT · Entity 4767 | Director | May 18, 2026 | May 21, 2026 |
| Nuwellis, Inc.NUWE · Entity 8478 | Director | May 19, 2023 | May 23, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ARTIVION, INC.
Report date May 18, 2026 · Filed May 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 137,416 |
Reported balance
After 2026-05-18 transaction · row 1
1 source rowRow 1 · 2026-05-18 · Grant · Acquired 7,576 · Balance 137,416 F1: RSA Grant vests on May 18, 2027, pursuant to the terms of the Equity and Cash Incentive Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: RSA Grant vests on May 18, 2027, pursuant to the terms of the Equity and Cash Incentive Plan.
Nuwellis, Inc.
Report date May 19, 2023 · Filed May 23, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Nonstatutory Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.02 · Expires 2033-05-18 | Direct | 2,146 |
Reported balance
After 2023-05-19 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-05-19 · Grant · Acquired 2,146 · Balance 2,146 F1: Vests in 12 approximately equal consecutive monthly increments, commencing on the one-month anniversary of the date of grant, so that all of the options will be vested on the one-year anniversary of the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Vests in 12 approximately equal consecutive monthly increments, commencing on the one-month anniversary of the date of grant, so that all of the options will be vested on the one-year anniversary of the date of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 18, 2026 Filed May 21, 2026 00:35 UTC | ARTIVION, INC. AORT · Entity 4767 | GrantCommon Stock | 7,576 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-037006 · wk-form4_1779323726.xml · nonDerivative · entry 1 Salveson Jon W · CIK 0001372026 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 137,416 F1 · shares: RSA Grant vests on May 18, 2027, pursuant to the terms of the Equity and Cash Incentive Plan. Read SEC document |
| May 22, 2025 Filed May 27, 2025 20:15 UTC | ARTIVION, INC. AORT · Entity 4767 | GrantCommon Stock | 6,325 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-25-000109 · wk-form4_1748376921.xml · nonDerivative · entry 1 Salveson Jon W · CIK 0001372026 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 129,840 F1 · shares: RSA Grant vests on May 22, 2026, pursuant to the terms of the Equity and Cash Incentive Plan. Read SEC document |
| May 30, 2024 Filed Jun 3, 2024 12:38 UTC | ARTIVION, INC. AORT · Entity 4767 | GrantCommon Stock | 6,289 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-24-000199 · wk-form4_1717418330.xml · nonDerivative · entry 1 Salveson Jon W · CIK 0001372026 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,515 F1 · shares: RSA Grant vests on May 30th 2025, pursuant to the terms of the Equity and Cash Incentive Plan. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 21:34 UTC | ARTIVION, INC. AORT · Entity 4767 | GrantCommon Stock | 9,709 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-23-000104 · wk-form4_1686260065.xml · nonDerivative · entry 1 Salveson Jon W · CIK 0001372026 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 117,226 F1 · balance_after: RSA Grant vests on June 6th 2024, pursuant to the terms of the Equity and Cash Incentive Plan? Read SEC document |
| May 19, 2023 Filed May 23, 2023 20:23 UTC | Nuwellis, Inc. NUWE · Entity 8478 | GrantNonstatutory Stock Option (right to buy) · Derivative | 2,146 | $0.00 Strike: $3.02 | $0.00 |
DisclosureSEC source: 0001140361-23-026252 · form4.xml · derivative · entry 1 Salveson Jon W · CIK 0001372026 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,146 Underlying: Common Stock · 2,146 shares Expires 2033-05-18 F1 · derivative.exercise_date: Vests in 12 approximately equal consecutive monthly increments, commencing on the one-month anniversary of the date of grant, so that all of the options will be vested on the one-year anniversary of the date of grant. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 20:46 UTC | ARTIVION, INC. AORT · Entity 4767 | GrantCommon Stock | 7,878 | $19.04 | $149,997.12 |
DisclosureSEC source: 0000784199-22-000149 · certent-form4.xml · nonDerivative · entry 1 Salveson Jon W · CIK 0001372026 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,517 F1 · shares: Represents shares of restricted stock that cliff vest on June 1, 2023, provided the status as a Director with Artivion continues through such date. Read SEC document |
| May 25, 2022 Filed May 26, 2022 20:30 UTC | Nuwellis, Inc. NUWE · Entity 8478 | GrantNonstatutory Stock Option (right to buy) · Derivative | 15,806 | $0.00 Strike: $0.62 | $0.00 |
DisclosureSEC source: 0001596771-22-000014 · primary_doc.xml · derivative · entry 1 Salveson Jon W · CIK 0001372026 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,806 Underlying: Common Stock · 15,806 shares Expires 2032-05-24 F1 · derivative.exercise_date: Vests in 12 approximately equal consecutive monthly increments, commencing on the one-month anniversary of the date of grant, so that all of the options will be vested on the one-year anniversary of the date of grant. Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 20:28 UTC | ARTIVION, INC. CRY · Entity 4767 | GrantCommon Stock | 4,423 | $29.39 | $129,991.97 |
DisclosureSEC source: 0000784199-21-000179 · certent-form4.xml · nonDerivative · entry 1 Salveson Jon W · CIK 0001372026 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,639 F1 · shares: Represents shares of restricted stock that cliff vest on June 1, 2022, provided the status as a Director with CryoLife continues through such date. Read SEC document |
| May 19, 2021 Filed May 20, 2021 20:54 UTC | Nuwellis, Inc. NUWE · Entity 8478 | GrantNonstatutory Stock Option (right to buy) · Derivative | 9,798 | $0.00 Strike: $3.63 | $0.00 |
DisclosureSEC source: 0001596771-21-000034 · primary_doc.xml · derivative · entry 1 Salveson Jon W · CIK 0001372026 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,798 Underlying: Common Stock · 9,798 shares Expires 2031-05-18 F1 · derivative.exercise_date: Vests in 12 approximately equal consecutive monthly increments, commencing on the one-month anniversary of the date of grant, so that all of the options will be vested on the one-year anniversary of the date of grant. Read SEC document |
| June 01, 2020 Filed Jun 2, 2020 20:50 UTC | ARTIVION, INC. CRY · Entity 4767 | GrantCommon Stock | 5,667 | $22.94 | $130,000.98 |
DisclosureSEC source: 0000784199-20-000167 · certent-form4.xml · nonDerivative · entry 1 Salveson Jon W · CIK 0001372026 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,216 F1 · shares: Represents shares of restricted stock that cliff vest on June 1, 2021, provided the status as a Director with CryoLife continues through such date. Read SEC document |
| May 20, 2020 Filed May 23, 2020 00:31 UTC | Nuwellis, Inc. CHFS · Entity 8478 | GrantNonstatutory Stock Option · Derivative | 18,849 | $0.00 Strike: $0.35 | $0.00 |
DisclosureSEC source: 0001567619-20-011104 · doc1.xml · derivative · entry 1 Salveson Jon W · CIK 0001372026 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,849 Underlying: Common Stock · 18,849 shares Expires 2030-05-19 F1 · derivative.exercise_date: Vests in 12 approximately equal consecutive monthly increments, commencing on the one-month anniversary of the date of grant, so that all of the options will be vested on the one-year anniversary of the date of grant. Read SEC document |
| May 05, 2020 Filed May 7, 2020 00:25 UTC | ARTIVION, INC. CRY · Entity 4767 | GrantCommon Stock | 1,399 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-20-000113 · certent-form4.xml · nonDerivative · entry 1 Salveson Jon W · CIK 0001372026 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,549 F1 · shares: RSA Covid grant vests on May 4, 2021, provided the status as a Director with CryoLife continues through such date. Read SEC document |
| May 23, 2019 Filed May 28, 2019 20:51 UTC | Nuwellis, Inc. CHFS · Entity 8478 | GrantNonstatutory Stock Option (right to buy) · Derivative | 1,970 | $0.00 Strike: $3.42 | $0.00 |
DisclosureSEC source: 0001596771-19-000051 · primary_doc.xml · derivative · entry 1 Salveson Jon W · CIK 0001372026 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,970 Underlying: Common Stock · 1,970 shares Expires 2029-05-22 F1 · derivative.exercise_date: Vests in 12 approximately equal consecutive monthly increments, commencing on the one-month anniversary of the date of grant, so that all of the options will be vested on the one-year anniversary of the date of grant. Read SEC document |
| May 16, 2019 Filed May 17, 2019 20:27 UTC | ARTIVION, INC. CRY · Entity 4767 | GrantCommon Stock | 4,163 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-19-000122 · certent-form4.xml · nonDerivative · entry 1 Salveson Jon W · CIK 0001372026 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,150 F1 · shares: Represents shares of restricted stock that cliff vest on May 16, 2020, provided the status as a Director with CryoLife continues through such date. Read SEC document |
| May 25, 2018 Filed May 29, 2018 20:50 UTC | Nuwellis, Inc. CHFS · Entity 8478 | GrantNonstatutory Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $3.01 | $0.00 |
DisclosureSEC source: 0001596771-18-000065 · primary_doc.xml · derivative · entry 1 Salveson Jon W · CIK 0001372026 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2028-05-24 F1 · derivative.exercise_date: Vests in 12 approximately equal consecutive monthly increments, commencing on the one-month anniversary of the date of grant, so that all of the options will be vested on the one-year anniversary of the date of grant. Read SEC document |
| May 23, 2018 Filed May 25, 2018 21:22 UTC | ARTIVION, INC. CRY · Entity 4767 | GrantCommon Stock | 4,638 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-18-000119 · certent-form4.xml · nonDerivative · entry 1 Salveson Jon W · CIK 0001372026 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,987 F1 · shares: Represents shares of restricted stock that cliff vest on May 23, 2019, provided the status as a Director with CryoLife continues through such date. Read SEC document |
| January 17, 2018 Filed Jan 19, 2018 21:38 UTC | Nuwellis, Inc. CHFS · Entity 8478 | GrantNonstatutory Stock Option (right to buy) · Derivative | 46,206 | $0.00 Strike: $3.55 | $0.00 |
DisclosureSEC source: 0001596771-18-000006 · primary_doc.xml · derivative · entry 1 Salveson Jon W · CIK 0001372026 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,206 Underlying: Common Stock · 46,206 shares Expires 2028-01-16 F1 · derivative.exercise_date: Vests in 12 approximately equal consecutive monthly increments, commencing on the one-month anniversary of the date of grant, so that all of the options will be vested on the one-year anniversary of the date of grant. Read SEC document |
| June 02, 2017 Filed Jun 6, 2017 20:35 UTC | Nuwellis, Inc. CHFS · Entity 8478 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 8,000 | $0.00 Strike: $0.57 | $0.00 |
DisclosureSEC source: 0001596771-17-000052 · primary_doc.xml · derivative · entry 1 Salveson Jon W · CIK 0001372026 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires 2027-06-01 F1 · derivative.exercise_date: Vests in 12 approximately equal consecutive monthly increments, commencing on the one-month anniversary of the date of grant, so that all of the options will be vested on the one-year anniversary of the date of grant. Read SEC document |
| May 17, 2017 Filed May 18, 2017 20:43 UTC | ARTIVION, INC. CRY · Entity 4767 | GrantCommon Stock | 5,263 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-17-000057 · certent-form4.xml · nonDerivative · entry 1 Salveson Jon W · CIK 0001372026 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,349 F1 · shares: Represents shares of restricted stock that vest on the first anniversary of the grant date if the reporting person remains a member of the Company's board of directors, subject to earlier vesting upon certain events including death, disability and retirement from the board after serving out his full term because the director is not standing for re-election at the end of the term. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.